The one question I’d like him to discuss and one
Post# of 148169
Obviously not every COVID19 patient will need leronlimab, but any displaying shortness of breath and/or requiring hospitalization should receive the medication to prevent further complications. That is still a significant number of patients in the U.S. and around the world.